Patents by Inventor Eric P. Berg
Eric P. Berg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11975121Abstract: The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention relates to protein biocoacervates and biomaterials that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled release of pharmacologically active agents, coated medical devices (e.g. stents, valves . . . ), vessels, tubular grafts, vascular grafts, wound healing devices including protein suture biomaterials and biomeshes, dental plugs and implants, skin/bone/tissue grafts, tissue fillers, protein biomaterial adhesion prevention barriers, cell scaffolding and other biocompatible biocoacervate or biomaterial devices.Type: GrantFiled: October 28, 2020Date of Patent: May 7, 2024Assignee: PETVIVO HOLDINGS, INC.Inventors: David B. Masters, Eric P. Berg
-
Patent number: 10967104Abstract: A stent system comprising zero or more inner stents inserted into an outer stent. The inner stents and outer stent are separated and/or encapsulated by a protein-based material of a protein matrix and/or a set biocoacervate, each comprising one or more biocompatible proteins and one or more biocompatible solvents. The protein-based material may also include one or more carbohydrates and one or more pharmacologically active agents.Type: GrantFiled: August 28, 2017Date of Patent: April 6, 2021Assignee: PETVIVO HOLDINGS, INC.Inventors: David B. Masters, Eric P. Berg
-
Publication number: 20210038764Abstract: The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention relates to protein biocoacervates and biomaterials that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled release of pharmacologically active agents, coated medical devices (e.g. stents, valves . . . ), vessels, tubular grafts, vascular grafts, wound healing devices including protein suture biomaterials and biomeshes, dental plugs and implants, skin/bone/tissue grafts, tissue fillers, protein biomaterial adhesion prevention barriers, cell scaffolding and other biocompatible biocoacervate or biomaterial devices.Type: ApplicationFiled: October 28, 2020Publication date: February 11, 2021Applicant: PETVIVO HOLDINGS, INC.Inventors: David B. Masters, Eric P. Berg
-
Patent number: 10850006Abstract: The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention relates to protein biocoacervates and biomaterials that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled release of pharmacologically active agents, coated medical devices (e.g. stents, valves . . . ), vessels, tubular grafts, vascular grafts, wound healing devices including protein suture biomaterials and biomeshes, dental plugs and implants, skin/bone/tissue grafts, tissue fillers, protein biomaterial adhesion prevention barriers, cell scaffolding and other biocompatible biocoacervate or biomaterial devices.Type: GrantFiled: May 16, 2018Date of Patent: December 1, 2020Assignee: PETVIVO HOLDINS, INC.Inventors: David B. Masters, Eric P. Berg
-
Publication number: 20190125928Abstract: The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention relates to protein biocoacervates and biomaterials that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled release of pharmacologically active agents, coated medical devices (e.g. stents, valves . . . ), vessels, tubular grafts, vascular grafts, wound healing devices including protein suture biomaterials and biomeshes, dental plugs and implants, skin/bone/tissue grafts, tissue fillers, protein biomaterial adhesion prevention barriers, cell scaffolding and other biocompatible biocoacervate or biomaterial devices.Type: ApplicationFiled: May 16, 2018Publication date: May 2, 2019Inventors: David B. Masters, Eric P. Berg
-
Publication number: 20190014766Abstract: A fishing system is disclosed. In one aspect, the fishing system includes a first fishing line segment terminating with a hook and a second fishing line segment terminating with a sinker. An attachment point can also be provided, wherein a first eyelet of the attachment point is slidably arranged on the first fishing line segment and a second eyelet of the attachment point is attached to the second fishing line segment. The fishing system can also include an immovable stopper attached to the first fishing line segment and a rigid or non-collapsing flexible tube spaced between the hook and the immovable stopper. In one aspect, the hook, stopper, and tube can move distally away from the first eyelet. The fishing system can also include a spherical ball spacer situated between the stopper and the first eyelet.Type: ApplicationFiled: July 11, 2018Publication date: January 17, 2019Inventor: Eric P. Berg
-
Publication number: 20180193534Abstract: A stent system comprising zero or more inner stents inserted into an outer stem. The inner stems and outer stent are separated and/or encapulated by a protein-based material of a protein matrix and/or a set biocoacervate, each comprising one or more biocompatible proteins and one or more biocompatible solvents. The protein-based material may also include one or more carbohydrates and one or more pharmacologically active agents.Type: ApplicationFiled: August 28, 2017Publication date: July 12, 2018Inventors: David B. Masters, Eric P. Berg
-
Patent number: 9999705Abstract: The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention relates to protein biocoacervates and biomaterials that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled release of pharmacologically active agents, coated medical devices (e.g. stents, valves . . . ), vessels, tubular grafts, vascular grafts, wound healing devices including protein suture biomaterials and biomeshes, dental plugs and implants, skin/bone/tissue grafts, tissue fillers, protein biomaterial adhesion prevention barriers, cell scaffolding and other biocompatible biocoacervate or biomaterial devices.Type: GrantFiled: August 17, 2015Date of Patent: June 19, 2018Assignee: Gel-Del Technologies, Inc.Inventors: David B. Masters, Eric P. Berg
-
Publication number: 20160158411Abstract: The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention relates to protein biocoacervates and biomaterials that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled release of pharmacologically active agents, coated medical devices (e.g. stents, valves . . . ), vessels, tubular grafts, vascular grafts, wound healing devices including protein suture biomaterials and biomeshes, dental plugs and implants, skin/bone/tissue grafts, tissue fillers, protein biomaterial adhesion prevention barriers, cell scaffolding and other biocompatible biocoacervate or biomaterial devices.Type: ApplicationFiled: August 17, 2015Publication date: June 9, 2016Inventors: David B. Masters, Eric P. Berg
-
Patent number: 9107937Abstract: Biomaterials and the related methods of making and using biomaterials for wound treatment. The biomaterial defines an amorphous material that is crosslinked with one or more crosslinking agents an includes aggregated complexes having homogenously distributed biocoacervated components. The biocoacervated components include one or more soluble or solubilized primary proteins combined with one or more glycosaminoglycans and one or more biocompatible solvents. The biomaterial can be utilized by administering the biomaterial to a wound.Type: GrantFiled: March 30, 2012Date of Patent: August 18, 2015Assignee: Gel-Del Technologies, Inc.Inventors: David B. Masters, Eric P. Berg
-
Publication number: 20140330252Abstract: The containment and fixation system of the present invention generally includes a biomatrix sleeve, biomatrix particles or combinations thereof made of a biomatrix material. The biomatrix material is comprised of one or more biocompatible proteins and one or more biocompatible solvents. The biomatrix material utilized in the sleeve and/or particles may also include one or more pharmacologically active agents like therapeutic biochemicals such as a bone mending biochemical (e.g. hydroxyapatite) or an angiogenic growth factor (e.g. BMP).Type: ApplicationFiled: January 7, 2014Publication date: November 6, 2014Inventors: David B. Masters, Eric P. Berg
-
Publication number: 20140107227Abstract: The present invention relates to mucoadhesive drug delivery devices and their methods of preparation and use. More specifically the present invention relates to mucoadhesive drug delivery devices comprising one or more biocompatible purified proteins combined with one or more biocompatible solvents and one or more mucoadhesive agents. The mucoadhesive drug delivery devices may also include one or more pharmacologically active agents. The drug delivery devices of the present invention adhere to mucosal tissue, thereby providing a vehicle for delivery of the pharmacologically active agent(s) through such tissue.Type: ApplicationFiled: September 10, 2013Publication date: April 17, 2014Inventors: David B. Masters, Eric P. Berg
-
Patent number: 8529939Abstract: The present invention relates to mucoadhesive drug delivery devices and their methods of preparation and use. More specifically the present invention relates to mucoadhesive drug delivery devices comprising one or more biocompatible purified proteins combined with one or more biocompatible solvents and one or more mucoadhesive agents. The mucoadhesive drug delivery devices may also include one or more pharmacologically active agents. The drug delivery devices of the present invention adhere to mucosal tissue, thereby providing a vehicle for delivery of the pharmacologically active agent(s) through such tissue.Type: GrantFiled: December 8, 2004Date of Patent: September 10, 2013Assignee: Gel-Del Technologies, Inc.Inventors: David B. Masters, Eric P. Berg
-
Patent number: 8465537Abstract: A stent system having zero or more inner stents inserted into an outer stent. The inner stents and outer stent are separated and/or encapsulated by a protein-based material of a protein matrix and/or a set biocoacervate, each one or more biocompatible proteins and one or more biocompatible solvents. The protein-based material may also include one or more carbohydrates and one or more pharmacologically active agents.Type: GrantFiled: June 17, 2004Date of Patent: June 18, 2013Assignee: Gel-Del Technologies, Inc.Inventors: David B. Masters, Eric P. Berg
-
Patent number: 8420153Abstract: A coating with antimicrobial agents for use with medical devices. In one approach, a related method involves coating high temperature vulcanized silicone material with a room temperature vulcanized dispersion.Type: GrantFiled: September 19, 2008Date of Patent: April 16, 2013Assignee: Mentor Worldwide LLCInventors: Eric P. Berg, Rita Stella
-
Patent number: 8419793Abstract: A coating with antimicrobial agents for use with medical devices. In one approach, a related method involves coating high temperature vulcanized silicone material with a room temperature vulcanized dispersion.Type: GrantFiled: March 12, 2010Date of Patent: April 16, 2013Assignee: Mentor Worldwide LLCInventors: Eric P. Berg, Rita Stella
-
Publication number: 20120282300Abstract: The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention relates to protein biocoacervates and biomaterials that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled release of pharmacologically active agents, coated medical devices (e.g. stents, valves . . . ), vessels, tubular grafts, vascular grafts, wound healing devices including protein suture biomaterials and biomeshes, dental plugs and implants, skin/bone/tissue grafts, tissue fillers, protein biomaterial adhesion prevention barriers, cell scaffolding and other biocompatible biocoacervate or biomaterial devices.Type: ApplicationFiled: March 30, 2012Publication date: November 8, 2012Applicant: GEL-DEL TECHNOLOGIES, INC.Inventors: David B. Masters, Eric P. Berg
-
Patent number: 8153591Abstract: The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention relates to protein biocoacervates and biomaterials that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled release of pharmacologically active agents, coated medical devices (e.g. stents, valves . . . ), vessels, tubular grafts, vascular grafts, wound healing devices including protein suture biomaterials and biomeshes, dental plugs and implants, skin/bone/tissue grafts, tissue fillers, protein biomaterial adhesion prevention barriers, cell scaffolding and other biocompatible biocoacervate or biomaterial devices.Type: GrantFiled: August 26, 2004Date of Patent: April 10, 2012Assignee: Gel-Del Technologies, Inc.Inventors: David B. Masters, Eric P. Berg
-
Publication number: 20110118818Abstract: A stent system comprising zero or more inner stents inserted into an outer stent. The inner stents and outer stent are separated and/or encapsulated by a protein-based material of a protein matrix and/or a set biocoacervate, each comprising one or more biocompatible proteins and one or more biocompatible solvents. The protein-based material may also include one or more carbohydrates and one or more pharmacologically active agents.Type: ApplicationFiled: June 17, 2005Publication date: May 19, 2011Inventors: David B. Masters, Eric P. Berg
-
Patent number: 7811317Abstract: A method for making an intravascular stent by applying to the body of a stent a solution which includes a solvent, a polymer dissolved in the solvent and a therapeutic substance dispersed in the solvent and then evaporating the solvent. The inclusion of a polymer in intimate contact with a drug on the stent allows the drug to be retained on the stent during expansion of the stent and also controls the administration of drug following implantation. The adhesion of the coating and the rate at which the drug is delivered can be controlled by the selection of an appropriate bioabsorbable or biostable polymer and the ratio of drug to polymer in the solution. By this method, drugs such as dexamethasone can be applied to a stent, retained on a stent during expansion of the stent and elute at a controlled rate.Type: GrantFiled: October 30, 2007Date of Patent: October 12, 2010Assignee: Medtronic, Inc.Inventors: Eric P. Berg, Ronald J. Tuch, Michael Dror, Rodney G. Wolff